SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is seeing intense community speculation ahead of its upcoming earnings report, with traders debating whether a recent surge in bullish call buying reflects a potential breakout or an orchestrated trap. Investors are heavily focused on the company's growth catalysts, including the removal of day-trading restrictions and a substantial share buyback program, while contending with stagnant price action near key support levels.

Micware Co. Ltd. engages in software development services and innovative IT solutions mainly focused on the automotive and mobility sectors. It operates through the following segments: Software Defined Vehicles (SDV), Location-Based Services (LBS), and Others. The SDV segment relates to the development and sale of software systems designed for SDV, including IVI system software and other mobility-enhancing software products, conducted by its Japanese subsidiaries. The LBS segment covers the development and licensing of in-vehicle navigation software systems, and other geographic data-based services for business-to-business customers, mainly serving end users. The Other segment comprises software development services conducted by overseas subsidiaries designed for SDV, and business-to-consumer mobile app services unrelated to in-vehicle navigation. The company was founded by Kenji Narishima in March 2003 and is headquartered in Kobe, Japan.

Micware Co. Ltd. - ADR

Micware Co. Ltd. (MWC) is experiencing extreme volatility and intense community speculation following a major surge triggered by its recent IPO, with investors heavily debating whether the stock is a high-growth opportunity backed by strategic partnerships with major automakers or a classic pump-and-dump scheme. The community is actively tracking technical support levels, analyzing massive volume spikes, and bracing for continued short-squeeze potential while closely monitoring the stock's wide price swings.

Applied Digital Corporation

Applied Digital is experiencing a significant surge in investor interest following the announcement of a massive new multi-billion dollar, 15-year lease agreement with a major hyperscaler for its fourth data center campus. The community is actively discussing the stock's strong execution in the AI infrastructure sector, highlighting a significant backlog of contracted revenue and the potential for a mechanical short squeeze as market sentiment shifts heavily toward a bullish outlook.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is facing intense volatility as investors weigh a strong Q1 earnings beat and bullish Q2 delivery guidance against broader market concerns and persistent allegations of share price manipulation. While the community is debating whether the stocks current valuation represents a deep-value buying opportunity following consistent quarterly profitability, many retail investors remain frustrated by the stock's stagnant price action relative to its improving fundamentals.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently trending as investors debate the sustainability of its rapid valuation growth amidst a broader semiconductor sector pullback and concerns over insider selling. While community sentiment is split between bullish long-term outlooks on its role in AI infrastructure and skepticism regarding its high price-to-earnings ratio, the stock remains a central focus for traders monitoring institutional flows and technical breakouts.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following the announcement of a 1 billion dollar government grant to establish a domestic quantum chip foundry, sparking intense discussion among investors regarding the company's long-term leadership in quantum computing. The market sentiment is divided, with some community members viewing the funding as a major validation of IBM's strategic pivot to AI and quantum infrastructure, while others remain skeptical about the stock's recent performance and are debating potential entry points for a long-term hold.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending following a proposed $100 million equity-backed investment from the U.S. government, sparking intense debate between bulls citing national strategic importance and bears pointing to fundamental concerns regarding low revenue and share dilution. The community remains deeply divided, with active discussion focusing on whether this government endorsement signals a long-term sector mandate or merely a volatile momentum play for speculative traders.

Intuit, Inc. engages in the provision of business and financial management solutions. It operates through the following segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business and Self-Employed segment offers QuickBooks financial and business management online services and desktop software, payroll solutions, payment processing solutions, and financing for small businesses. The Consumer segment includes do-it-yourself and assisted TurboTax income tax preparation products and services. The Credit Karma segment serves consumers with a personal finance platform that provides personalized recommendations of credit cards, home, auto and personal loans, and insurance products, and online savings and checking accounts. The ProTax segment refers to the professional accountants in the U.S. and Canada, who are essential to both small business success and tax preparation and filing. The company was founded by Scott D. Cook and Thomas A. Proulx in March 1983 and is headquartered in Mountain View, CA.

Intuit Inc

Intuit is facing intense selling pressure despite reporting a double beat on earnings and raising full-year guidance, as investors react negatively to a 17% workforce reduction and concerns over competitive pricing for DIY tax filers. The community is actively debating whether this is a massive institutional transfer of ownership and an oversold buying opportunity, or if the stock is suffering from a fundamental re-rating driven by long-term fears regarding AI disruption in the software sector.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is experiencing a surge in community interest driven by a combination of high short interest and a shrinking float fueled by active share repurchases. Investors are actively discussing the potential for a massive short squeeze, comparing the setup to previous market volatility events while emphasizing the company's improving fundamentals.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is currently in focus as investors analyze the retailer's latest earnings and annual guidance, while debating whether its valuation remains sustainable amidst persistent consumer cost pressures and broader economic volatility. The community is actively discussing the company's role as a consumer bellwether, its pivot toward high-margin advertising and membership revenue, and its ability to maintain resilience despite shifting discretionary spending patterns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Teva Stock Up More Than 100% in a Year: Time to Buy, Hold or Sell? 

Teva's branded drug growth, biosimilar launches and improving margins are strengthening its long-term outlook despite generics pressure.

Ralph Baric And UNC's Biodefense Contract Racket Exposed

Ralph Baric And UNC's Biodefense Contract Racket Exposed Authored by Paul D. Thacker via The DisInformation Chronicle, DLA Piper wants to get you, I was told, from a source in DC over the weekend...

DNLI Q1 Loss Narrower Than Expected, Avlayah Approval Boosts Prospects

Denali narrows its Q1 loss and gains FDA approval for Avlayah, the first new Hunter syndrome treatment option in nearly 20 years.

NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal Momentum

Novavax's shares rise 16% after Q1 earnings beat estimates as the company expands Matrix-M partnerships across oncology and infectious diseases.

<ul class="summary-bullets"><li>Novavax posted Q1 revenue of $139.5 million, above analysts’ estimate of $78.3 million, helped by licensing agreements.</li><li>The drugmaker also said that patients who received Nuvaxovid were “twice as likely” to say they would choose the same vaccine again the following year.</li><li>The company maintained its 2026 adjusted revenue outlook of $230 million to $270 million.</li></ul>Shares of Novavax (NVAX) are headed for a breakout week as the vaccine maker reported solid first quarter (Q1) results and spotlighted data showing that patients were “twice as likely” to choose its COVID shot again over a rival vaccine from Moderna<a href="https://stocktwits.com/symbol/NVAX">NVAX stock</a> jumped 16% on Wednesday to end at $9.36. Shares are eyeing their best week in about nine months.<h2 class="st-heading-2">Novavax Touts Lower Side Effects Vs Moderna</h2>Novavax reported Q1 revenue of $139.5 million, beating analysts’ estimate of $78.3 million. The results were boosted by upfront and milestone payments from licensing and vaccine supply partnerships as the company shifts away from relying primarily on direct COVID vaccine sales.The rally also came as investors focused on fresh data comparing Novavax’s protein-based COVID vaccine, Nuvaxovid, against Moderna’s mNEXSPIKE shot.During the earnings call, Novavax highlighted findings from Sanofi’s head-to-head Phase IV Compare study, which tested Nuvaxovid directly against Moderna’s vaccine. The Maryland-based company said Nuvaxovid showed “statistically fewer side effects compared to mNEXSPIKE, across all prespecified endpoints.”Novavax added that people who received Nuvaxovid were “twice as likely as mNEXSPIKE recipients to say they would definitely choose the same vaccine type again the following year.” The company also pointed to real-world data from the Shield study conducted with the University of Utah, saying that participants who received Nuvaxovid reported fewer side effects and “half as many hours of lost work” compared with recipients of mRNA vaccines.The findings are notable since Novavax’s turnaround depends on its protein-based vaccine as a differentiated alternative in the crowded COVID and future combination flu-COVID market. Novavax believes the combined COVID-flu vaccine market could eventually represent a $10 billion to $12 billion opportunity.<h2 class="st-heading-2">Pfizer, Sanofi Deals Fuel NVAX Optimism</h2>While demand for standalone COVID vaccines has weakened globally, Novavax is leaning on licensing agreements and partnerships to drive growth. The company received a $30 million upfront payment during the quarter from its Matrix-M adjuvant agreement with pfizer. Matrix-M is Novavax’s in-house ingredient that helps the body build a stronger immune response after vaccination.&nbsp;“Despite whatever is happening in the macro environment, there seems to be a very strong interest,” CEO John C. Jacobs said during the conference call. The company said that its partners are currently exploring over 30 infectious disease and cancer indications using Matrix-M.&nbsp;“Our partnerships with Sanofi and Pfizer have the potential on their own, to generate billions in revenue from milestone and royalty opportunities,” Jacobs said. Sanofi is developing combination flu-COVID vaccines using Nuvaxovid under a deal worth at least $1.2 billion.<h2 class="st-heading-2">NVAX Reaffirms 2026 Revenue Outlook</h2>Novavax maintained its 2026 adjusted revenue forecast in the range of $230 million and $270 million, excluding royalties and sales from the Sanofi agreement. The company also reiterated that it expects its existing cash position and partner reimbursements to fund operations into 2028 even without additional milestones or royalty revenue. Novavax posted a Q1 net loss of just $9 million and continues targeting non-GAAP profitability by 2028.&nbsp;After the earnings report and updated vaccine data, TD Cowen raised its price target on Novavax to $9 from $8, still implying a 4% downside from current levels, while maintaining a ‘Hold’ rating. The brokerage cited the Sanofi-led head-to-head study and growing evidence that Nuvaxovid may offer a differentiated tolerability profile compared with other mRNA vaccines.<h2 class="st-heading-2">How Do Retail Traders Feel About NVAX?</h2>On Stocktwits, retail sentiment for NVAX was ‘extremely bullish’ amid over a 430% surge in 24-hour message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/nvax_ss_png_50a26f969e.webp" alt="nvax ss.png" width="968" height="142"><figcaption>NVAX sentiment and message volume as of May 7 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/topstockalerts/message/652530627">said</a>, “not chasing but definitely watching this closely”<stembedurl>https://stocktwits.com/topstockalerts/message/652530627</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/Bodu/message/652514332">said</a>, “Lean organization, massive $100 billion market. No rush. Im not expecting to be rich tomorrow but I do expect it to happen in a year”<stembedurl>https://stocktwits.com/Bodu/message/652514332</stembedurl>NVAX stock has risen 54% over the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nio-stock-es9-launch-drowns-out-fresh-ubs-sell-down/cZXbcphRefg">Nio Stock Jumps In HK: ES9 Launch Buzz Drowns Out Fresh UBS Sell-Down&nbsp;</a>

 Ampoules containing the new Corona vaccine Nuvaxovid from the manufacturer Novavax sit on a table at a vaccination center. Photo: Matthias Bein/dpa (Photo by Matthias Bein/picture alliance via Getty Images)

NVAX Stock Eyes Breakout Week: Novavax Claims Patients Were ‘Twice As Likely’ To Pick Its COVID Shot Over Moderna Again 

The company spotlighted new data showing that its COVID vaccine, Nuvaxovid, produced “statistically fewer side effects” than Moderna’s mNEXSPIKE vaccine.

Equity

Sanofi $SNY Shares Sold by UBS Group AG

UBS Group AG reduced its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and...

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

BMRN misses Q1 EPS estimates despite a revenue beat, as charges and higher costs weigh on profits, while new Amicus deal lifts the 2026 outlook.

Sanofi (NASDAQ:SNY) Sets New 1-Year Low  - Should You Sell?

Sanofi (NASDAQ:SNY) Sets New 12-Month Low - Time to Sell...

Sanofi (NASDAQ:SNY) Shares Gap Down Following Analyst Downgrade

Sanofi (NASDAQ:SNY) Shares Gap Down Following Analyst Downgrade...

M&T Bank Corp Sells 402,012 Shares of Sanofi $SNY

M&T Bank Corp trimmed its stake in Sanofi (NASDAQ:SNY - Free Report) by 97.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,531 shares of the company's stock after selling 402,012 shares during the period. M&T Bank Corp's holdi...

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.08	--	--	N/A
Q1 '26	$1.04	$1.10	6.21%	BEAT
Q4 '25	$0.84	$0.91	8.38%	BEAT
Q3 '25	$1.58	$1.69	7.23%	BEAT
Q2 '25	$0.96	$0.91	-5.11%	MISSED

SNY
Sanofi-Aventis

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest SNY News

SNYSanofi-Aventis